Omada Health, Inc. financial data

Symbol
OMDA on Nasdaq
Location
611 Gateway Blvd., Suite 120, South San Francisco, CA
Latest financial report
10-Q - Q3 2025 - Nov 7, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 57.9M shares
Common Stock, Shares, Outstanding 57.9M shares
Common Stock, Value, Issued 58K USD
Weighted Average Number of Shares Outstanding, Basic 57.7M shares +640%
Weighted Average Number of Shares Outstanding, Diluted 57.7M shares +640%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 68M USD +49.5%
Cost of Revenue 23M USD +35.4%
Research and Development Expense 10.3M USD +16.4%
Selling and Marketing Expense 22.9M USD +30.5%
General and Administrative Expense 14.3M USD +34.5%
Operating Income (Loss) -2.51M USD +70.5%
Nonoperating Income (Expense) -665K USD +5.27%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.18M USD +65.6%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -3.18M USD +65.6%
Earnings Per Share, Basic -0.06 USD/shares +94.9%
Earnings Per Share, Diluted -0.06 USD/shares +94.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 199M USD
Accounts Receivable, after Allowance for Credit Loss, Current 41.4M USD
Inventory, Net 3.15M USD
Assets, Current 255M USD
Property, Plant and Equipment, Net 7.54M USD
Operating Lease, Right-of-Use Asset 0 USD
Intangible Assets, Net (Excluding Goodwill) 2.85M USD
Goodwill 13.2M USD
Other Assets, Noncurrent 199K USD
Assets 287M USD
Accounts Payable, Current 5.34M USD
Accrued Liabilities, Current 37.6M USD
Contract with Customer, Liability, Current 27.2M USD
Liabilities, Current 70.1M USD
Other Liabilities, Noncurrent 0 USD
Liabilities 70.1M USD
Retained Earnings (Accumulated Deficit) -462M USD
Stockholders' Equity Attributable to Parent 217M USD
Liabilities and Equity 287M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 750M shares
Common Stock, Shares, Issued 57.9M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 199M USD +137%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -3.18M USD +65.6%
Operating Lease, Liability, Current 0 USD
Preferred Stock, Shares Authorized 10M shares
Additional Paid in Capital 679M USD
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 3.54M USD +63.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares